The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.

Michael Martin,Suphak Vanichseni,Pravan Suntharasamai,Udomsak Sangkum,Philip A. Mock,Manoj Leethochawalit,Sithisat Chiamwongpaet,Marcel E. Curlin,Supawadee Na-pompet,Anchalee Warapronmongkholkul,Somyot Kittimunkong,Roman Gvetadze,Janet M. McNicholl,Lynn Paxton,Kachit Choopanya

The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.

2015

Michael Martin
Suphak Vanichseni
Pravan Suntharasamai
Udomsak Sangkum
Philip A. Mock
Manoj Leethochawalit
Sithisat Chiamwongpaet
Marcel E. Curlin
Supawadee Na-pompet
Anchalee Warapronmongkholkul
Somyot Kittimunkong
Roman Gvetadze
Janet M. McNicholl
Lynn Paxton
Kachit Choopanya

Objective:To describe participant adherence to daily oral tenofovir in an HIV preexposure prophylaxis (PrEP) trial, examine factors associated with adherence, and assess the impact of adherence on the risk of HIV infection.Design:The Bangkok Tenofovir Study was a randomized, double-blind, placebo-co

Keywords:

Immunology
Tenofovir
Medicine
Internal medicine
Lower risk
Demographics
human immunodeficiency virus
poor adherence
Logistic regression
Proportional hazards model
risk behavior

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations